Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey F Waring

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Neuroscience Research|January 1, 2008
Analysis of gene expression profiles in rat hippocampus following treatment with nicotine and an alpha7 nAChR selective agonistJeffrey F Waring, Stephen Abel, Jinhe Li, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 22, 2008
Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injuryPatrick J Shaw, Amy C Ditewig, Jeffrey F Waring, et al.
Plos One|June 1, 2018
Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimensAparna Vasanthakumar, Justin W Davis, Manal Abunimeh, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's DiseaseJeffrey F Waring, Qi Tang, Weining Z Robieson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2005
Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophilsJeffrey F Waring, Michael J Liguori, James P Luyendyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 23, 2006
Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocationXiaomin Deng, Robert F Stachlewitz, Michael J Liguori, et al.
EHP Toxicogenomics : Journal of the National Institute of Environmental Health Sciences|May 9, 2003
Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequencesJeffrey F Waring, Guy Cavet, Robert A Jolly, et al.
Brain Research|December 1, 2009
Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's diseaseNathan R Rustay, Elizabeth A Cronin, Peter Curzon, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitorsDale J Kempf, Jeffrey F Waring, David C Morfitt, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2015
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 studyAnthony W Tolcher, Patricia LoRusso, Jennifer Arzt, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Neuroscience Research|January 1, 2008
Analysis of gene expression profiles in rat hippocampus following treatment with nicotine and an alpha7 nAChR selective agonistJeffrey F Waring, Stephen Abel, Jinhe Li, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 22, 2008
Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injuryPatrick J Shaw, Amy C Ditewig, Jeffrey F Waring, et al.
Plos One|June 1, 2018
Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimensAparna Vasanthakumar, Justin W Davis, Manal Abunimeh, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's DiseaseJeffrey F Waring, Qi Tang, Weining Z Robieson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2005
Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophilsJeffrey F Waring, Michael J Liguori, James P Luyendyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 23, 2006
Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocationXiaomin Deng, Robert F Stachlewitz, Michael J Liguori, et al.
EHP Toxicogenomics : Journal of the National Institute of Environmental Health Sciences|May 9, 2003
Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequencesJeffrey F Waring, Guy Cavet, Robert A Jolly, et al.
Brain Research|December 1, 2009
Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's diseaseNathan R Rustay, Elizabeth A Cronin, Peter Curzon, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Practical preclinical model for assessing the potential for unconjugated hyperbilirubinemia produced by human immunodeficiency virus protease inhibitorsDale J Kempf, Jeffrey F Waring, David C Morfitt, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2015
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 studyAnthony W Tolcher, Patricia LoRusso, Jennifer Arzt, et al.
Pageof 7